7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
A clinician-reviewed deep dive into the emerging biological mechanisms behind male hypogonadism, covering hypothalamic-pituitary signaling, metabolic drivers, epigenetic factors, and what these findings mean for diagnosis and treatment in 2024.
A comprehensive review of the socioeconomic burden of male hypogonadism, including direct medical costs, lost productivity, mental health consequences, and the cost-effectiveness of testosterone replacement therapy.
A clinician-reviewed overview of male hypogonadism prevalence worldwide, secular trends, risk factors, and what the latest epidemiological data mean for diagnosis and treatment.
A physician-reviewed timeline of male hypogonadism treatment from early organotherapy in the 1800s through modern testosterone formulations, GnRH analogs, and emerging peptide therapies, with primary-source citations throughout.
An evidence-based review of unresolved male-hypogonadism questions: diagnostic thresholds, assay quality, obesity-related low testosterone, TRT cardiovascular and prostate safety, fertility, and long-term outcomes.
A clinical deep-dive into how race and ethnicity shape testosterone levels, hypogonadism diagnosis rates, and treatment access in men across the United States, with primary-source citations throughout.
A clinical deep-dive into rare and atypical presentations of male hypogonadism, including fertile eunuch syndrome, Kallmann syndrome variants, late-onset hypogonadism without classic symptoms, and medication-induced forms, with primary-source citations and practical diagnostic guidance.